End-of-day quote
Shanghai S.E.
06:00:00 2024-05-23 pm EDT
|
5-day change
|
1st Jan Change
|
36.3
CNY
|
-2.76%
|
|
+6.61%
|
-23.32%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,035
|
5,858
|
5,184
|
7,038
|
5,397
|
-
|
-
|
Enterprise Value (EV)
1 |
4,035
|
5,858
|
5,184
|
7,038
|
5,397
|
5,397
|
5,397
|
P/E ratio
|
46.8
x
|
43.1
x
|
-
|
56.4
x
|
28.1
x
|
16.8
x
|
12.8
x
|
Yield
|
-
|
1.87%
|
-
|
1.69%
|
3.04%
|
3.53%
|
6.9%
|
Capitalization / Revenue
|
14.2
x
|
14.4
x
|
11.3
x
|
13.6
x
|
7.49
x
|
4.49
x
|
3.4
x
|
EV / Revenue
|
14.2
x
|
14.4
x
|
11.3
x
|
13.6
x
|
7.49
x
|
4.49
x
|
3.4
x
|
EV / EBITDA
|
39.2
x
|
36
x
|
-
|
39.5
x
|
18.6
x
|
12.7
x
|
9.22
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.55
x
|
3.54
x
|
3.1
x
|
3.96
x
|
2.91
x
|
2.59
x
|
2.49
x
|
Nbr of stocks (in thousands)
|
143,348
|
143,348
|
143,726
|
148,677
|
148,677
|
-
|
-
|
Reference price
2 |
28.15
|
40.87
|
36.07
|
47.34
|
36.30
|
36.30
|
36.30
|
Announcement Date
|
2/26/21
|
2/24/22
|
2/27/23
|
2/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
283.5
|
405.9
|
458.1
|
517.3
|
720.3
|
1,202
|
1,589
|
EBITDA
1 |
103
|
162.6
|
-
|
178.3
|
290.3
|
423.8
|
585.5
|
EBIT
1 |
76.06
|
134.9
|
116.4
|
122.9
|
201.2
|
327.6
|
438
|
Operating Margin
|
26.83%
|
33.24%
|
25.41%
|
23.76%
|
27.93%
|
27.25%
|
27.57%
|
Earnings before Tax (EBT)
1 |
78.05
|
147.4
|
116.1
|
122.3
|
199.7
|
337.4
|
439
|
Net income
1 |
71.92
|
136.1
|
113.1
|
122.3
|
191.7
|
321.1
|
422.4
|
Net margin
|
25.36%
|
33.52%
|
24.7%
|
23.64%
|
26.62%
|
26.72%
|
26.59%
|
EPS
2 |
0.6020
|
0.9490
|
-
|
0.8400
|
1.290
|
2.162
|
2.840
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.7653
|
-
|
0.8000
|
1.105
|
1.280
|
2.505
|
Announcement Date
|
2/26/21
|
2/24/22
|
2/27/23
|
2/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
8.56%
|
8.4%
|
6.79%
|
7.2%
|
10.4%
|
15.4%
|
19.5%
|
ROA (Net income/ Total Assets)
|
5.05%
|
6.47%
|
-
|
5.61%
|
7.53%
|
9.82%
|
12.1%
|
Assets
1 |
1,425
|
2,103
|
-
|
2,181
|
2,546
|
3,269
|
3,482
|
Book Value Per Share
2 |
11.00
|
11.60
|
11.60
|
12.00
|
12.50
|
14.00
|
14.60
|
Cash Flow per Share
2 |
0.8400
|
0.9800
|
-
|
0.1700
|
2.530
|
2.330
|
3.250
|
Capex
1 |
162
|
251
|
-
|
204
|
301
|
264
|
269
|
Capex / Sales
|
57.04%
|
61.73%
|
-
|
39.36%
|
41.79%
|
21.92%
|
16.93%
|
Announcement Date
|
2/26/21
|
2/24/22
|
2/27/23
|
2/24/24
|
-
|
-
|
-
|
Last Close Price
36.3
CNY Average target price
55
CNY Spread / Average Target +51.52% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.32% | 745M | | +3.47% | 103B | | -8.02% | 61.43B | | +72.86% | 49.09B | | +15.48% | 38.46B | | +3.64% | 32.09B | | +13.29% | 20.39B | | +12.53% | 16.78B | | +15.34% | 14.76B | | +0.39% | 13.73B |
Other Commodity Chemicals
|